Bisantrene
- CAS NO.:78186-34-2
- Empirical Formula: C22H22N8
- Molecular Weight: 398.46
- MDL number: MFCD00872137
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-03-30 18:40:43
What is Bisantrene?
Originator
Bisantrene hydrochloride,ZYF Pharm Chemical
The Uses of Bisantrene
Antineoplastic.
Definition
ChEBI: A hydrazone resulting from the formal condensation of both of the aldehyde groups of anthracene-9,10-dicarbaldehyde with 2-hydrazinyl-4,5-dihydro-1H-imidazole.
Manufacturing Process
A 33.0 g (0.135 mole) of 2-methylthio-2-imidazoline hydroiodide is dissolved
in 300 ml of water and treated with 8 ml (0.16 mole) of hydrazine hydrate.
The mixture is stirred at room temperature for 20 hours and then taken to
dryness under reduced pressure. The residue is dissolved in 250 ml of water
and again taken to dryness under reduced pressure. The residue is
redissolved in 250 ml of water and added to a mixture of 250 ml of water, 25
ml of concentrated hydrochloric acid and 25 g of silver oxide. The resulting
mixture is stirred on a steam bath for 4 hours and then filtered. The filtrate is
reduced to dryness under reduced pressure. The residue is dissolved in 300
ml of ethanol and 20 ml of water at the boil, clarified and cooled at -10°C.
The precipitate is collected, washed with ethanol and ether and dried at 60°C
and then 110°C under reduced pressure. Yield of the 2-hydrazino-2-
imidazoline hydrochloride 11.6 g, melting point 177-180°C.
The 2-hydrazino-2-imidazoline monohydrochloride is converted to the
dihydrochloride by treatment with ethanol and concentrated hydrochloric acid.
A suspension of 3.46 g of the 2-hydrazino-2-imidazoline dihydrochloride and
2.34 g of 9,10-anthracenedicarboxaldehyde in 100 ml of ethanol is stirred and
heated under reflux for two hours. The mixture is cooled and the solid is
collected and washed with ethanol giving the desired product as a crystalline
orange solid, m.p. 288-289°C (dec.).
Therapeutic Function
Antineoplastic
Properties of Bisantrene
| Boiling point: | 646.3±65.0 °C(Predicted) |
| Density | 1.41±0.1 g/cm3(Predicted) |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | deionized water: soluble8mg/mL |
| form | solid |
| pka | 9.78±0.10(Predicted) |
| color | Orange to red |
Safety information for Bisantrene
| Signal word | Warning |
| Pictogram(s) |
![]() Exclamation Mark Irritant GHS07 ![]() Environment GHS09 |
| GHS Hazard Statements |
H302:Acute toxicity,oral H400:Hazardous to the aquatic environment, acute hazard |
| Precautionary Statement Codes |
P273:Avoid release to the environment. |
Computed Descriptors for Bisantrene
| InChIKey | NJSMWLQOCQIOPE-OCHFTUDZSA-N |
| SMILES | C1(/C=N/NC2=NCCN2)=C2C=CC=CC2=C(/C=N/NC2=NCCN2)C2C=CC=CC1=2 |
New Products
N Nitroso Amlodipine (S)-Lansoprazole/Lansoprazole S-Isomer N-Nitroso Gabapentin EP Impurity A Imatinib Impurity B/ Imatinib Impurity 1 Losartan EP Impurity K/Losartan USP Related Compound C / Losartan Aldehyde Escitalopram EP Impurity E/Escitalopram Open Ring (USP) 2-(Ethoxymethylene)propanedinitrile 4-dimethylaminopyridine 3-Bromo-2-Methyl-5-Nitropyridine 5-Chloro-pyridine-2-carboxylic acid amide 2-Amino-4-Methylpyridine 4-AminopyridineRelated products of tetrahydrofuran








You may like
-
Bisantrene dihydrochloride CAS 78186-34-2View Details
78186-34-2 -
Lorazepam EP Impurity D NLT 95%View Details
54699-91-1 -
29144-31-8 (S)-N-Formyl Octabase(S-Isomer) (Levomethorphan Intermediate) NLT 95%View Details
29144-31-8 -
73959-98-5 NLT 95%View Details
73959-98-5 -
Bupropion Amine Hydrochloride NLT 95%View Details
2227990-16-9 -
Losartan Azide impurity NLT 95%View Details
727718-93-6 -
2955-37-5 Lorazepam EP Impurity C NLT 95%View Details
2955-37-5 -
S-Thioctic Acid Tromethamine 248914-06-9 NLT 95%View Details
248914-06-9


